ERBB2 and neoplasm: Together, these current findings demonstrated the FN‐lowering ESR1 expression for suppression of cell proliferation, FN‐reducing TP53 expression for inhibition of gene mutation and tumour growth, and FN‐decreasing ERBB2 expression for blocking neoplastic development and metastasis.